Crossmark Global Holdings, Inc. Ani Pharmaceuticals Inc Transaction History

Crossmark Global Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 28, 2020	SELL	$30.35 - $67.14 $126,256 - $279,302	-4,160 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$55.65 - $79.83 $35,616 - $51,091	640 Added 18.18%	4,160 $257,000
Q2 2018 Jul 31, 2018	BUY	$56.38 - $68.08 $198,457 - $239,641	3,520 New	3,520 $235,000
Q1 2018 Apr 16, 2018	SELL	$56.98 - $72.41 $191,452 - $243,297	-3,360 Closed	0 $0
Q4 2017 Feb 05, 2018	SELL	$53.3 - $74.56 $50,102 - $70,086	-940 Reduced 21.86%	3,360 $217,000
Q3 2016 Oct 25, 2017	BUY	N/A	4,300	4,300 $226,000

211

18.7M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $930M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.